Reply to Letter to the Editor: "Risk Factors Associated With Fatal Thrombosis in COVID-19" regarding: "Improving Risk Analysis for Fatal Thrombosis in COVID-19: A Call for Targeted Anticoagulation"

Heart Lung Circ. 2024 Nov;33(11):e63-e65. doi: 10.1016/j.hlc.2024.10.003.

Authors

Ankit Agrawal¹, Umesh Bhagat¹, Aro Daniela Arockiam¹, Elio Haroun¹, Tom Kai Ming Wang²

Affiliations

¹ Department of Cardiovascular Medicine, Heart, Vascular, and Thoracic Institute, Cleveland Clinic, Cleveland, OH, USA.
² Department of Cardiovascular Medicine, Heart, Vascular, and Thoracic Institute, Cleveland Clinic, Cleveland, OH, USA. Electronic address: [email protected].

PMID: 39521580
DOI: 10.1016/j.hlc.2024.10.003

No abstract available

Keywords: COVID-19; Fatal thrombosis.

Publication types

Letter